Home » Tenders » Europe » Germany » Open House Contracts for Several Active Ingredients / Active Ingredient Combinations Tender

Open House Contracts for Several Active Ingredients / Active Ingredient Combinations Tender

Download Documents

AOK NORTHWEST - THE HEALTH INSURANCE has floated a tender for Open House Contracts for Several Active Ingredients / Active Ingredient Combinations. The project location is Germany and the tender is closing on 01 Sep 2022. The tender notice number is 247109-2021, while the TOT Ref Number is 53151424. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Open House Contracts for Several Active Ingredients / Active Ingredient Combinations

Deadline : 01 Sep 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 53151424

Document Ref. No. : 247109-2021

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK NORTHWEST - THE HEALTH INSURANCE
Address: Copenhagener Str. 1
Town: Dortmund
Nuts code: DEA - North Rhine-Westphalia
Postal Code: 44269
Germany
Email :openhouse@nw.aok.de
URL :www.aok.de

Tender Details

Document Type: Corrigendum / Additional Information (please refer to the Tender Document)

Title: Open House contracts for several active ingredients / active ingredient combinations

Reference Number: 2020-10-12-NW-Kra-Open House

Contract Type: Supplies

Description: The subject of this publication is the conclusion of contracts pursuant to Section 130a (8) SGB V on the following active substances / active ingredient combinations within the framework of a so-called open-house procedure:

- Bimatoprost (S01E03),

- Budenonid (A07EA06) only hard capsules with changed drug release,

- aprovitant (A04AD12) excl. Packs of 2 components and N1 packs with WS thickness 80 mg,

- Cinacalcet (H05BX01),

- iron (II) sulfate (B03AA07),

- hydroxychloroquin (P01BA02),

- Lenogastrim (L03AA10),

- Nadroparin (B01AB06),

- Emtricitabine / Tenofovirdisoproxil / Rilpivirin (J05AR08),

- Nitrofurantoin (J01XE01),

- Clonazepam (N03AE01).

Under default of contract terms and a uniform access procedure, all appropriate and interested pharmaceutical companies or communities of pharmaceutical companies will be completed by the conclusion of a discount agreement according to § 130 ...